Suven Pharmaceuticals Ltd - 543064 - Outcome Of The Board Meeting
Outcome of the Board Meeting30-05-2024
30-05-2024
Suven Pharmaceuticals Ltd - 543064 - Outcome Of The Board Meeting
Outcome of the Board Meeting30-05-2024
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Further to our letter dated May 21st , 2024, this is to inform you that the conference call for investors scheduled on Thursday, May 30, 2024 at 07:00 P.M IST to discuss the Audited Financial Results for the Q4 & FY24, has been preponed and rescheduled on Thursday, May 30, 2024 at 06.00 P.M IST to discuss the Audited Financial Results for the Q4 & FY24, to be declared on May 30, 2024. The revised invitation for conducting the conference call for investors is enclosed.27-05-2024
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the management of the Company would be participating in the B&K - Trinity India Conference on Friday, 31st May 2024 Note: The schedule of the aforesaid meetings is subject to change. The change may happen due to exigencies on the part of Analyst / Institutional Investor / Company. No unpublished price-sensitive information will be shared during this interaction.27-05-2024
Suven Pharmaceuticals Ltd - 543064 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Submission of Annual Secretarial Compliance Report for the F.Y. ended 31st March 202427-05-2024
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Further to our letter dated May 20th, 2024, this is to inform you that the conference call for investors scheduled on Monday, May 27, 2024 at 07:00 P.M IST to discuss the Audited Financial Results for the Q4 & FY24, has been postponed and rescheduled on Thursday, May 30, 2024 at 07.00 P.M IST to discuss the Audited Financial Results for the Q4 & FY24, to be declared on May 30, 2024. The revised invitation for conducting the conference call for investors is enclosed.21-05-2024
Suven Pharmaceuticals Ltd - 543064 - Update on board meeting
The Board Meeting to be held on 27/05/2024 has been revised to 30/05/2024 Further to our letter dated May 20th, 2024, this is to inform you that the meeting of the Board of Directors of the Company scheduled to be held on May 27, 2024, at the Corporate Office, 202, A-Wing, Galaxy Towers, Plot No.1, Hyderabad Knowledge City, TSIIC, Raidurg, Hyderabad, Telangana - 500081 of the Company, inter alia, to consider and approve the Audited Standalone and Consolidated financial results of the Company for the fourth quarter and financial year ended March 31, 2024 has been postponed and rescheduled to Thursday May 30th 2024. We would also like to inform that the Earnings Conference Call, which was scheduled on Monday 27th May 2024, at 7.00 p.m. (IST), to discuss on the Company's Audited Financial Results, has also been postponed accordingly. The revised Earnings Conference Call details will be notified through separate communication.21-05-2024
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to above subject, please find enclosed herewith an invitation for conducting the conference call for investors on Monday, May 27, 2024 at 07:00 P.M IST to discuss the Audited Financial Results for the Q4 & FY24, to be declared on May 27, 2024.20-05-2024
Suven Pharmaceuticals Ltd - 543064 - Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Be Held On Monday, The 27Th May, 2024
Suven Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 ,inter alia, to consider and approve With reference to above subject, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that a Meeting of the Board of Directors of the Company will be held on Monday, the 27th May, 2024 at 05:30 p.m. IST at the Corporate Office, 202, A-Wing, Galaxy Towers, Plot No.1, Hyderabad Knowledge City, TSIIC, Raidurg, Hyderabad, Telangana - 500081 of the Company, to consider, inter alia, and approve the following matter(s): To consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the fourth quarter and year ended March 31, 2024 and other matters. Please further note that TRADING WINDOW for dealing in the securities of the company is already closed from 01st April, 2024 as per PIT Code of the Company. Trading window will be opened from 30th May, 2024. You are requested to take this notice on your record.20-05-2024
Suven Pharmaceuticals Ltd - 543064 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st March 202410-04-2024